Leslie Chong

Leslie Chong has extensive experience in the biotechnology and pharmaceutical sectors, currently serving as the Chief Executive Officer and Managing Director of Imugene Limited since September 2015. Previous roles include Non-Executive Director at Chimeric Therapeutics and the Cure Brain Cancer Foundation, as well as senior positions at Genentech and Roche. Leslie's career began as a CTM/Project Manager at PPD and includes a significant tenure as Associate Director at Exelixis and Study Manager at GSK. Leslie holds a Bachelor of Science in Biology, Physical Anthropology, Art History, and Museum Studies from the University of North Carolina at Greensboro, as well as a Master of Fine Arts from the University of North Carolina at Chapel Hill.